Vol. I · No. 49

The considered read on the medspa world

IndustryProfessional & trade

Preventive aesthetic plans rise as GLP‑1 and menopause shape trends

Recent survey shows growing demand for preventive aesthetic plans with natural‑looking results. GLP‑1, AI tools and menopause are reshaping priorities in 2026.

By
Ian Gauntt, RN, BSN
Filed under
Industry
Published
September 15, 2026
Sources cited
10
Evidence
Tier 2 · Professional & trade
A woman in a white dress smiling and touching her face

Key Takeaways

  • Most consumers want subtle, natural-looking preventive aesthetic treatments.
  • GLP‑1 use, menopause, and AI are influencing how people choose treatments.
  • Interest in longevity-oriented options like peptides is rising.
  • Fewer than 10% of consumers follow structured long-term aesthetic plans.

What do preventive aesthetic plans mean to consumers?

Preventive aesthetic plans reflect a shift toward subtle, long-term care that maintains rather than reverses aging. A NewBeauty report finds 90.5% of respondents say looking refreshed is very or extremely important, and 72.6% list preventing future signs of aging as their leading goal (fidelity.com). That emphasis aligns with a wider move toward natural-looking results and durability. Collagen-stimulating treatments and longevity-focused enhancements are gaining traction (perfectcorp.com).

How are GLP‑1 drugs reshaping aesthetic priorities?

Consumers on GLP‑1 therapies often face loose skin and facial volume loss, prompting aesthetic plans focused on restoration and natural balance. In one survey, 42% cited loose or sagging skin as the leading body concern post-weight-loss, while 40.4% pointed to muscle tone issues (fidelity.com). Providers are building combination protocols—injectable biostimulators, radiofrequency microneedling, even mRNA collagen therapies—to meet these needs, according to a McKinsey industry poll (mckinsey.com).

What role does menopause play in aesthetic choices?

Menopause drives new priorities for treatments addressing hormonal skin and body changes. In NewBeauty Summer 2026 data, 76.6% of respondents undergoing menopause want energy-based treatments like lasers or RF microneedling; 70.8% want skin care for menopausal skin, and over half would try fillers for volume restoration (fidelity.com). Industry surveys note growing patient motivation tied to menopause as a trigger for seeking aesthetic care (surgicalaesthetics.industry411.com).

Are AI tools and peptides influencing treatment planning?

AI enters the consumer journey through visualization and research tools. About 30% of consumers have used AI to explore treatments, and 67% would use AI to compare procedures (fidelity.com). Interest in peptides for skin health or anti-aging runs above 80%, with 54.1% very interested and another 27.3% somewhat curious (newbeauty.com).

Why aren't more consumers following long-term plans?

Only about 9% of aesthetic consumers follow a long-term treatment plan with a provider, despite widespread interest in how they want to look (fidelity.com). That gap reflects a mismatch between engaged consumers and structured care strategies. Providers can guide more patients with personalized roadmaps rather than isolated procedures (fidelity.com).

FAQ

What are preventive aesthetic plans?

Preventive aesthetic plans focus on subtle, ongoing treatments that maintain a natural look and delay signs of aging rather than correcting them later.

How do GLP‑1 drugs affect aesthetic treatment needs?

GLP‑1 users commonly experience loose skin and volume loss, pushing demand for combination therapies like fillers, biostimulators, and energy-based devices to restore balance.

Why are menopause and energy-based treatments linked?

Women in menopause report skin and body changes, and many seek energy-based treatments such as lasers and RF microneedling along with specialized skin care.

How is AI impacting aesthetic consumer behavior?

About one-third of consumers have used AI to research treatments, and most are comfortable using it to compare procedures or visualize outcomes.

What's driving interest in peptides for longevity in aesthetics?

Peptides rank among the top emerging treatments for skin health and anti-aging, with over 80% of consumers expressing at least some interest.

Why are so few people following long-term aesthetic plans?

Despite consumer engagement, only about 9% follow long-term treatment plans—many still approach aesthetics through discrete procedures rather than structured care.

Disclaimer: This article is for general information and is not medical advice. Aesthetic treatment results vary by individual. Consult a licensed, qualified provider before pursuing any cosmetic procedure.

Sources

  1. T
  2. T
  3. T
  4. T
  5. T
  6. T
  7. T
  8. T
  9. T
  10. T

How we tier evidence →

No corrections to date · Report an error

MedSpa Daily is an editorial publication, not a medical provider. Nothing here is medical advice — consult a licensed clinician about your own care.

← Return to today's edition